Nucleic acid delivery of immune-focused SARS-CoV-2 nanoparticles drives rapid and potent immunogenicity capable of single-dose protection

被引:19
作者
Konrath, Kylie M. [1 ,2 ]
Liaw, Kevin [1 ]
Wu, Yuanhan [1 ]
Zhu, Xizhou [1 ]
Walker, Susanne N. [1 ]
Xu, Ziyang [1 ,2 ]
Schultheis, Katherine [3 ]
Chokkalingam, Neethu [1 ]
Chawla, Himanshi [4 ]
Du, Jianqiu [5 ]
Tursi, Nicholas J. [1 ]
Moore, Alan [5 ]
Adolf-Bryfogle, Jared [6 ]
Purwar, Mansi [1 ]
Reuschel, Emma L. [1 ]
Frase, Drew [1 ]
Sullivan, Matthew [2 ]
Fry, Benjamin [1 ]
Maricic, Igor [3 ]
Andrade, Viviane M. [3 ]
Iffland, Christel [7 ]
Crispin, Max [4 ]
Broderick, Kate E. [3 ]
Humeau, Laurent M. P. F. [3 ]
Patel, Ami [1 ]
Smith, Trevor R. F. [3 ]
Pallesen, Jesper [6 ]
Weiner, David B. [1 ]
Kulp, Daniel W. [1 ,2 ]
机构
[1] Wistar Inst Anat & Biol, Vaccine & Immunotherapy Ctr, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
[3] Inovio Pharmaceut, Plymouth Meeting, PA 19462 USA
[4] Univ Southampton, Sch Biol Sci, Southampton SO17 1BJ, Hants, England
[5] Indiana Univ, Mol & Cellular Biochem, Bloomington, IN 47405 USA
[6] Inst Prot Innovat, Boston, MA 02115 USA
[7] Ligand Pharmaceut Inc, San Diego, CA 92121 USA
关键词
RECEPTOR-BINDING DOMAIN; NEUTRALIZING ANTIBODIES; HEMAGGLUTININ-STEM; VACCINES; PROTEIN; VIRUS; INFECTION; RESPONSES; DESIGN; SITE;
D O I
10.1016/j.celrep.2022.110318
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines may target epitopes that reduce durability or increase the potential for escape from vaccine-induced immunity. Using synthetic vaccinology, we have developed rationally immune-focused SARS-CoV-2 Spike-based vaccines. Glycans can be employed to alter antibody responses to infection and vaccines. Utilizing computational modeling and in vitro screening, we have incorporated glycans into the receptor-binding domain (RBD) and assessed antigenic profiles. We demonstrate that glycan-coated RBD immunogens elicit stronger neutralizing antibodies and have engineered seven multivalent configurations. Advanced DNA delivery of engineered nanoparticle vaccines rapidly elicits potent neutralizing antibodies in guinea pigs, hamsters, and multiple mouse models, including human ACE2 and human antibody repertoire transgenics. RBD nanoparticles induce high levels of cross-neutralizing antibodies against variants of concern with durable titers beyond 6 months. Single, low-dose immunization protects against a lethal SARS-CoV-2 challenge. Single-dose coronavirus vaccines via DNA-launched nanoparticles provide a platform for rapid clinical translation of potent and durable coronavirus vaccines.
引用
收藏
页数:26
相关论文
共 79 条
[61]  
Wang X.G., NATURE, V579, P270
[62]   Glycan Shielding of the Influenza Virus Hemagglutinin Contributes to Immunopathology in Mice [J].
Wanzeck, Keith ;
Boyd, Kelli L. ;
McCullers, Jonathan A. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183 (06) :767-773
[63]  
Watanabe Y, 2020, SCIENCE, V369, P330, DOI [10.1126/science.abb9983, 10.1101/2020.03.26.010322]
[64]   Exploitation of glycosylation in enveloped virus pathobiology [J].
Watanabe, Yasunori ;
Bowden, Thomas A. ;
Wilson, Ian A. ;
Crispin, Max .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2019, 1863 (10) :1480-1497
[65]   Antibody neutralization and escape by HIV-1 [J].
Wei, XP ;
Decker, JM ;
Wang, SY ;
Hui, HX ;
Kappes, JC ;
Wu, XY ;
Salazar-Gonzalez, JF ;
Salazar, MG ;
Kilby, JM ;
Saag, MS ;
Komarova, NL ;
Nowak, MA ;
Hahn, BH ;
Kwong, PD ;
Shaw, GM .
NATURE, 2003, 422 (6929) :307-312
[66]   A new coronavirus associated with human respiratory disease in China [J].
Wu, Fan ;
Zhao, Su ;
Yu, Bin ;
Chen, Yan-Mei ;
Wang, Wen ;
Song, Zhi-Gang ;
Hu, Yi ;
Tao, Zhao-Wu ;
Tian, Jun-Hua ;
Pei, Yuan-Yuan ;
Yuan, Ming-Li ;
Zhang, Yu-Ling ;
Dai, Fa-Hui ;
Liu, Yi ;
Wang, Qi-Min ;
Zheng, Jiao-Jiao ;
Xu, Lin ;
Holmes, Edward C. ;
Zhang, Yong-Zhen .
NATURE, 2020, 579 (7798) :265-+
[67]   An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain [J].
Wu, Nicholas C. ;
Yuan, Meng ;
Liu, Hejun ;
Lee, Chang-Chun D. ;
Zhu, Xueyong ;
Bangaru, Sandhya ;
Torres, Jonathan L. ;
Caniels, Tom G. ;
Brouwer, Philip J. M. ;
van Gils, Marit J. ;
Sanders, Rogier W. ;
Ward, Andrew B. ;
Wilson, Ian A. .
CELL REPORTS, 2020, 33 (03)
[68]   A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2 [J].
Wu, Yan ;
Wang, Feiran ;
Shen, Chenguang ;
Peng, Weiyu ;
Li, Delin ;
Zhao, Cheng ;
Li, Zhaohui ;
Li, Shihua ;
Bi, Yuhai ;
Yang, Yang ;
Gong, Yuhuan ;
Xiao, Haixia ;
Fan, Zheng ;
Tan, Shuguang ;
Wu, Guizhen ;
Tan, Wenjie ;
Lu, Xuancheng ;
Fan, Changfa ;
Wang, Qihui ;
Liu, Yingxia ;
Zhang, Chen ;
Qi, Jianxun ;
Gao, George Fu ;
Gao, Feng ;
Liu, Lei .
SCIENCE, 2020, 368 (6496) :1274-+
[69]   A DNA-Launched Nanoparticle Vaccine Elicits CD8+ T-cell Immunity to Promote In Vivo Tumor Control [J].
Xu, Ziyang ;
Chokkalingam, Neethu ;
Tello-Ruiz, Edgar ;
Wise, Megan C. ;
Bah, Mamadou A. ;
Walker, Susanne ;
Tursi, Nicholas J. ;
Fisher, Paul D. ;
Schultheis, Katherine ;
Broderick, Kate E. ;
Humeau, Laurent ;
Kulp, Daniel W. ;
Weiner, David B. .
CANCER IMMUNOLOGY RESEARCH, 2020, 8 (11) :1354-1364
[70]   Incorporation of a Novel CD4+ Helper Epitope Identified from Aquifex aeolicus Enhances Humoral Induced DNA and Protein Vaccinations [J].
Xu, Ziyang ;
Chokkalingam, Neethu ;
Tello-Ruiz, Edgar ;
Walker, Susanne ;
Kulp, Daniel W. ;
Weiner, David B. .
ISCIENCE, 2020, 23 (08)